학술논문
FusionVAC22_01: a phase I clinical trial evaluating a DNAJB1-PRKACA fusion transcript-based peptide vaccine combined with immune checkpoint inhibition for fibrolamellar hepatocellular carcinoma and other tumor entities carrying the oncogenic driver fusion
Document Type
Article
Author
Source
In: Frontiers in Oncology . (Frontiers in Oncology, 2024, 14)
Subject
Language
English
ISSN
2234943X